Biaxial Mechanical Characterizations of Atrioventricular Heart Valves
April 9th, 2019
14.6K views
This protocol involves characterizations of atrioventricular valve leaflets with force-controlled, displacement-controlled, and stress-relaxation biaxial mechanical testing procedures. Results acquired with this protocol can be used for constitutive model development to simulate the mechanical behavior of functioning valves under a finite element simulation framework.
Overview
This protocol involves characterizations of atrioventricular valve leaflets using biaxial mechanical testing procedures. It provides insights into heart valve biomechanics, aiding in computational modeling and treatment refinement for heart valve disease.
Key Study Components
Area of Science
- Biomechanics
- Cardiovascular Research
- Soft Tissue Mechanics
Background
- Understanding heart valve mechanics is crucial for developing treatment methods.
- Existing protocols may not provide a unified testing scheme.
- Biaxial testing allows for comprehensive mechanical characterizations.
- This study focuses on atrioventricular valve leaflets.
Purpose of Study
- To characterize the mechanical properties of heart valve tissues.
- To improve computational models of heart valve function.
- To refine treatment methods for heart valve disease.
Methods Used
- Force-controlled and displacement-controlled biaxial testing.
- Stress-relaxation testing procedures.
- Unified testing scheme for mechanical characterizations.
- Preparation of leaflet specimens for testing.
Main Results
- Characterization data can inform constitutive model development.
- Results enhance understanding of valve mechanics under physiological conditions.
- Methodology is advantageous for soft tissue biomechanics research.
- Protocol can be applied to other soft tissues beyond heart valves.
Conclusions
- This protocol offers a comprehensive approach to valve mechanics.
- It can significantly impact computational modeling in cardiovascular research.
- Future applications may extend to various soft tissue studies.
Frequently Asked Questions
What is the significance of this testing protocol?
It provides a unified approach to mechanical characterization of heart valve tissues, enhancing understanding and modeling.
How does this protocol compare to existing methods?
It offers a more comprehensive and unified testing scheme for characterizing heart valve biomechanics.
What are the potential applications of this research?
Applications include improving treatment methods for heart valve disease and advancing soft tissue biomechanics research.
What types of mechanical testing are involved?
The protocol includes force-controlled, displacement-controlled, and stress-relaxation biaxial testing.
Can this method be applied to other tissues?
Yes, it can be beneficial for characterizing other soft tissues such as arterial vessels and skin.
What is the first step in the protocol?
The first step involves removing the leaflet specimen from PBS storage and preparing it for testing.
Executive Industry Relevance
Biaxial mechanical characterization of atrioventricular heart valve leaflets provides quantitative biomechanical data essential for refining computational models of valve function under physiological loading. This unified testing approach supports target validation in cardiovascular therapeutic development by enabling mechanistic de-risking through reproducible, anisotropic tissue property measurements. The resulting constitutive model parameters improve predictive confidence in preclinical simulations of valve repair or replacement strategies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by quantifying nonlinear, anisotropic mechanical responses of valve leaflet tissues.
- Operational Value: Provides standardized tissue preparation and testing protocols that reduce variability in biomechanical assessments.
- Predictive Value: Supports predictive confidence in lead identification by linking biomechanical properties to functional outcomes in disease models.
Screening & Assay Development
- Scientific Value: Generates validated biological systems with defined mechanical phenotypes for downstream compound screening.
- Operational Value: Ensures assay standardization and reproducibility through force-controlled, displacement-controlled, and stress-relaxation testing modalities.
- Scalability: Facilitates platform reuse across soft tissue types, enabling consistent evaluation of therapeutic candidates.
Translational & Preclinical Research
- Scientific Value: Aligns with disease-relevant systems by characterizing mitral and tricuspid valve leaflet mechanics under physiological strain conditions.
- Operational Value: Provides continuity from discovery through preclinical validation via transferable biomechanical endpoints.
- Risk Mitigation: Supports risk-adjusted advancement decisions by quantifying tissue-level mechanical de-risking in valvular pathologies.
Pipeline & Workflow Integration
The method integrates into the discovery continuum by supplying biomechanical readouts that inform hypothesis testing, assay readiness, and translational continuity in cardiovascular target validation.
- Discovery Biology: Supports pathway clarification and biological de-risking through quantitative mapping of leaflet tissue responses to biaxial loading.
- Screening: Enables assay readiness via standardized specimen preparation and reproducible mechanical outputs across testing cycles.
- Analytics: Delivers stress-strain curves, anisotropy indices, and relaxation kinetics that allow comparative analysis of tissue conditions.
- Translational Research: Connects to preclinical validation by providing biomechanical benchmarks for healthy versus diseased tissue states.
- Enterprise Reuse: Establishes a reusable capability for soft tissue biomechanics applicable across cardiovascular and related therapeutic areas.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence by reducing mechanistic ambiguity in valve tissue behavior under load.
- Operational Value: Delivers standardization, reproducibility, and scalability through unified force- and displacement-controlled protocols.
- Strategic Value: Improves go/no-go decisions by enabling data-driven selection of targets with favorable biomechanical profiles.
- Portfolio Impact: Informs risk-adjusted prioritization by quantifying tissue-level contributions to valve function and failure modes.
Implementation Considerations
- Requires expertise in biomechanical testing, tissue handling, and digital image correlation for accurate deformation analysis.
- Dependent on access to a commercial biaxial mechanical tester with force and displacement control capabilities.
- Necessitates cross-team standardization of specimen orientation, thickness measurement, and fiducial marker placement.
- Involves adaptation considerations when applying the protocol to different tissue types or disease models.
- Includes practical limitations such as potential shear stress contributions, which are presumed negligible but should be monitored.
Biopharma FAQs
Why does null hypothesis testing matter for target validation in biaxial mechanical characterization?
Null hypothesis testing determines whether observed differences in leaflet mechanical properties between conditions are statistically significant, supporting confident target selection in cardiovascular discovery programs.
How does independent variable isolation fit the discovery pipeline for heart valve biomechanics?
Isolating variables such as loading direction and strain rate enables precise measurement of anisotropic tissue responses, which clarifies structure-function relationships critical for target validation.
What quantitative dependent variable measurements enable mechanistic de-risking in valve tissue studies?
Dependent variables including stress, strain, and relaxation kinetics provide quantitative readouts that link tissue mechanics to functional outcomes, reducing uncertainty in preclinical modeling.
Why do replication requirements matter for cross-functional collaboration in biaxial testing?
Replication ensures consistency of mechanical data across teams and sites, enabling reliable comparison of valve tissue phenotypes in multi-disciplinary R&D efforts.
What statistical analysis capabilities are required before implementing biaxial mechanical testing in target validation workflows?
Capabilities such as nonlinear curve fitting, anisotropy quantification, and hypothesis testing are needed to derive constitutive model parameters and assess significance of mechanical differences between tissue states.
Chapters in this video
0:04
Title
0:37
Tissue Dissection
1:40
Thickness Measurement, Biaxial Tester Setup, and Fiducial Marker Placement
2:48
Preconditioning and Duration Timing
4:51
Biaxial Mechanical Testing
8:48
Results: Representative Displacement-Controlled and Stress Relaxation Protocol Analyses
10:24
Conclusion
